These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29143737)

  • 1. Validation of ELISA methods for quantification of the major birch allergen Bet v 1 (BSP090).
    Kaul S; Zimmer J; Dehus O; Constanzo A; Daas A; Buchheit KH; Asturias J; Arilla MC; Barber D; Bertocchi A; Brunetto B; Carnes JA; Chapman M; Chaudemanche G; Dayan-Kenigsberg J; Döring S; Führer F; Gallego MT; Iacovacci P; Hanschmann KM; Holzhauser T; Hrabina M; Ledesma A; Moingeon P; Nony E; Pini C; Plunkett G; Raulf M; Reese G; Sandberg E; Sander I; Smith B; Strecker D; Valerio C; van Ree R; Weber B; Vieths S
    Pharmeur Bio Sci Notes; 2017; 2017():69-87. PubMed ID: 29143737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1.
    Kaul S; Zimmer J; Dehus O; Costanzo A; Daas A; Buchheit KH; Asturias JA; Barber D; Carnés J; Chapman M; Dayan-Kenigsberg J; Döring S; Führer F; Hanschmann KM; Holzhauser T; Ledesma A; Moingeon P; Nony E; Pini C; Plunkett G; Reese G; Sandberg E; Sander I; Strecker D; Valerio C; van Ree R; Vieths S
    Allergy; 2016 Oct; 71(10):1414-24. PubMed ID: 27018782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies.
    Vieths S; Barber D; Chapman M; Costanzo A; Daas A; Fiebig H; Hanschmann KM; Hrabina M; Kaul S; Ledesma A; Moingeon P; Reese G; Schörner C; van Ree R; Weber B; Buchheit KH
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():118-34. PubMed ID: 23327896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and in-house validation of an allergen-specific ELISA for quantification of Bet v 4 in diagnostic and therapeutic birch allergen products.
    Dehus O; Zimmer J; Döring S; Führer F; Hanschmann KM; Holzhauser T; Neske F; Strecker D; Trösemeier JH; Vieths S; Kaul S
    Anal Bioanal Chem; 2015 Feb; 407(6):1673-83. PubMed ID: 25572690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardisation of allergen products: 4. Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5.
    Zimmer J; Schmidt S; Kaul S; Costanzo A; Buchheit KH; Brown S; Carnés J; Chapman M; Chen A; De Neergaard M; Döring S; Hindley JP; Holzhauser T; Jorajuria S; Le Tallec D; Lombardero M; Iacovacci P; Reese G; Sander I; Smith B; Strecker D; van Ree R; Zebina M; Vieths S
    Allergy; 2022 Feb; 77(2):633-642. PubMed ID: 34241919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an ELISA method for quantification of the major Timothy grass pollen allergen Phl p 5a (BSP090).
    Zimmer J; Schmidt S; Costanzo A; Buchheit KH; Brown S; Carnés J; Chapman M; Chen A; De Neergaard M; Döring S; Hindley J; Holzhauser T; Jorajuria S; Le Tallec D; Lombardero M; Iacovacci P; Reese G; Sander I; Smith B; Strecker D; van Ree R; Zebina M; Kaul S; Vieths S
    Pharmeur Bio Sci Notes; 2022; 2022():55-86. PubMed ID: 36511317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor allergen patterns in birch pollen allergen products-A question of pollen?
    Zimmer J; Döring S; Strecker D; Trösemeier JH; Hanschmann KM; Führer F; Vieths S; Kaul S
    Clin Exp Allergy; 2017 Aug; 47(8):1079-1091. PubMed ID: 28493312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.
    Brier S; Le Mignon M; Jain K; Lebrun C; Peurois F; Kellenberger C; Bordas-Le Floch V; Mascarell L; Nony E; Moingeon P
    Allergy; 2018 May; 73(5):1032-1040. PubMed ID: 29171882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of major allergen references and ELISAs--current state of the BSP090 project.
    Kaul S; Dehus O; Zimmer J; Vieths S
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():45-53. PubMed ID: 24912312
    [No Abstract]   [Full Text] [Related]  

  • 11. Engineering, purification and applications of His-tagged recombinant antibody fragments with specificity for the major birch pollen allergen, bet v1.
    Flicker S; Laffer S; Steinberger P; Alhani B; Zhu Y; Laukkanen ML; Keinänen K; Kraft D; Valenta R
    Biol Chem; 2000 Jan; 381(1):39-47. PubMed ID: 10722049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for Quality Control of Allergen Products with Mass Spectrometry.
    Spiric J; Schulenborg T; Schwaben L; Engin AM; Karas M; Reuter A
    J Proteome Res; 2017 Oct; 16(10):3852-3862. PubMed ID: 28821210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
    Movérare R; Westritschnig K; Svensson M; Hayek B; Bende M; Pauli G; Sorva R; Haahtela T; Valenta R; Elfman L
    Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of capillary zone electrophoresis and capillary isoelectric focusing separations optimized for the characterization of two recombinant products of the birch pollen allergen Bet v 1a.
    Kronsteiner B; Dullnig V; Stutz H
    Electrophoresis; 2008 Jun; 29(12):2539-49. PubMed ID: 18512676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
    Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
    J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere.
    Schäppi GF; Suphioglu C; Taylor PE; Knox RB
    J Allergy Clin Immunol; 1997 Nov; 100(5):656-61. PubMed ID: 9389296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression and purification of the major birch pollen allergen, Bet v 1.
    Hoffmann-Sommergruber K; Susani M; Ferreira F; Jertschin P; Ahorn H; Steiner R; Kraft D; Scheiner O; Breiteneder H
    Protein Expr Purif; 1997 Feb; 9(1):33-9. PubMed ID: 9116499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Mal d 1 and Api g 1 - specific recombinant antibodies from mouse IgG Fab fragment libraries - Mal d 1-specific antibody exhibits cross-reactivity against Bet v 1.
    Haka J; Niemi MH; Iljin K; Reddy VS; Takkinen K; Laukkanen ML
    BMC Biotechnol; 2015 May; 15():34. PubMed ID: 26013405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of General Chapters on standard methods for allergen quantification in the European Pharmacopoeia.
    Zimmer J; Bonertz A; Kaul S; Vieths S
    Allergy; 2023 Apr; 78(4):923-927. PubMed ID: 36579359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.